DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Zinner N, Tuttle J, Marks L.
Efficacy and tolerability of darifenacin, a muscarinic M3 selective receptor antagonist (M3 SRA), compared with oxybutynin in the treatment of patients with overactive bladder.
World J Urol 2005;
23: 248-252
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.